The mission details of the funder are not explicitly provided in the given description.
The grant program supports scientific conferences that align with the mission of accelerating drug development for Alzheimer's disease. Grants of up to $10,000 are provided to fund conferences that contribute to the understanding, prevention, treatment, and cure of Alzheimer's. This initiative is part of the ADDF's broader effort to bridge funding gaps in early-stage drug research by supporting pioneering ideas and projects that might not otherwise receive necessary financial backing from pharmaceutical companies, federal agencies, or other major entities.